HBA-MSH C.S.H.B. 3155 77(R)BILL ANALYSIS


Office of House Bill AnalysisC.S.H.B. 3155
By: Capelo
Public Health
4/10/2001
Committee Report (Substituted)



BACKGROUND AND PURPOSE 

According to the American Diabetes Association, 15.7 million people or 5.9
percent of the population of the United States have diabetes.  One child
out of every 600 develops Type 1 diabetes.  The Texas Department of Health
estimates that in 1998, 1.6 million adult Texans or 12 percent of the
state's population had diabetes.  It is estimated that in 1990 there were
9,320 Texans under age 18 who had Type 1 diabetes.   From 1993 to 1998, the
number of children under age 18 with type 2 diabetes tripled. Diabetes can
produce complications such as blindness, kidney disease, nerve damage,
heart disease, and stroke. Many of the components associated with the
disease are unknown and need further research. C.S.H.B. 3155 requires the
commissioner of health in consultation with the Texas Diabetes Council to
establish a Pediatric Diabetes Research Advisory Committee to develop of a
plan to investigate the scientific research opportunities for pediatric
diabetes. 

RULEMAKING AUTHORITY

It is the opinion of the Office of House Bill Analysis that this bill does
not expressly delegate any additional rulemaking authority to a state
officer, department, agency, or institution. 

ANALYSIS

C.S.H.B. 3155 requires the commissioner of health (commissioner) in
consultation with the Texas Diabetes Council to establish a pediatric
diabetes research advisory committee (advisory committee) and sets forth
requirements for the composition of the committee.  The bill requires the
advisory committee to conduct analyses and assessments for the purpose of
providing advice to the legislature and governor on the development of a
plan to investigate the scientific research opportunities for pediatric
diabetes in the state as well as to assess resources, talent, and the
economic and health-related diabetes burden. The bill requires the advisory
committee to submit a report to the governor, lieutenant governor, and
speaker of the house or representatives not later than December 1, 2002.
The bill sets forth provisions relating to the composition and appointment
of members of the advisory committee as well as the appointment of a chair
by the commissioner.  The bill provides for the termination of the group on
January 1, 2003. 

EFFECTIVE DATE

On passage, or if the Act does not receive the necessary vote, the Act
takes effect September 1, 2001. 

COMPARISON OF ORIGINAL TO SUBSTITUTE

C.S.H.B. 3155 differs from the original by changing the name of the entity
created by the bill from the pediatric diabetes research-plan group to the
pediatric diabetes research advisory committee (advisory committee).  The
substitute specifies to whom the advisory committee's report is to be
submitted and the deadline for the submission.  The substitute provides for
the abolition of the advisory committee on  January 1, 2003 and changes the
effective date of the bill from 90 days after adjournment to the date of
passage. The substitute conforms the original to Texas Legislative Council
style and format.